2,861 results on '"Clinically isolated syndrome"'
Search Results
2. Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion (POLAR)
3. Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
4. A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab (SOPRANINO)
5. A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy (MINORE)
6. Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. (RECLAIM)
7. Glymphatic MRI in Clinically Isolated Syndrome
8. MS-ResearchBiomarkerS (MS-ReBS)
9. Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis (T4MS)
10. Understanding Magnetic Resonance Imaging in Multiple Sclerosis (UMIMS)
11. Multi-omics profiling reveals peripheral blood biomarkers of multiple sclerosis: implications for diagnosis and stratification.
12. Cerebrospinal fluid neurofilament light chain in acute optic neuritis and its predictive ability of multiple sclerosis.
13. Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial.
14. Proteomics and Management of Multiple Sclerosis
15. Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
16. Clinico-radiologic Spectrum and Outcome of Pediatric Acquired Demyelinating Disorders of Central Nervous System: A Retrospective Indian Tertiary Care Hospital Cohort.
17. Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics.
18. COGNITIVE IMPAIRMENT IN DIFFERENT CLINICAL FORMS OF MULTIPLE SCLEROSIS
19. Prognostic relevance of the C‐X‐C motif chemokine ligand 13 and interleukin‐8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
20. Brain microstructure is linked to cognitive fatigue in early multiple sclerosis.
21. Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?
22. Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders.
23. Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset (IMPACT MS)
24. Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome (OBIT)
25. China National Registry of Neuro-Inflammatory Diseases (CNRID)
26. Autoimmune Intervention Mastery Course Study (AIM)
27. Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017
28. Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study
29. Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017.
30. Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study.
31. Real-life evaluation of the 2017 McDonald criteria for relapsing–remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.
32. Bilateral horizontal gaze palsy as an initial presentation of a clinically isolated syndrome: A case report.
33. Minocycline in MS: Confirmation of Benefit (MS)
34. Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System (MSPT)
35. Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI (PIXCIS)
36. Risk Factors in Early Multiple Sclerosis (RISEMS)
37. Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
38. Síndrome clínico aislado: diagnóstico y riesgo de desarrollar esclerosis múltiple clínicamente definida
39. The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS
40. Ocrelizumab in Breastmilk
41. Migréna a roztroušená skleróza.
42. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
43. Functional MRI of Multiple Sclerosis
44. Case Report: Chorea an unusual presentation of a patient with clinically isolated syndrome (multiple sclerosis) [version 1; peer review: awaiting peer review]
45. Evaluation of Diffusion Tensor Imaging Findings in Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis Patients
46. Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
47. Distinct hemodynamic and functional connectivity features of fatigue in clinically isolated syndrome and multiple sclerosis: accounting for the confounding effect of concurrent depression symptoms.
48. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
49. The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome.
50. Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.